A recent report by Lehmann-Werman et al. showed the utility of using cfDNA to detect cell loss in MS, by measuring demethylated cfDNA of MBP and WM1 genes, showing an increase in the levels of demethylated DNA in patients with MS (Lehmann-Werman et al., 2016). The gene discussed is MBP; the disease is myeloid sarcoma.